|
Market Closed -
OTC Markets
15:06:37 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| 12-28 | Motion for Asset Sale Approved for Seelos Therapeutics, Inc. | CI |
| 25-10-21 | GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q). | CI |
Business description: Seelos Therapeutics, Inc.
Number of employees: 8
Sales by Activity: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
Pharmaceuticals | 375K | - | - | - | 2.2M |
Geographical breakdown of sales: Seelos Therapeutics, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) |
|---|---|---|---|---|---|
United States | 375K | - | - | - | 2.2M |
Executive Committee: Seelos Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 66 | 2018-12-31 |
| Director of Finance/CFO | 54 | 2021-08-31 | |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Marciano
IRC | Investor Relations Contact | - | 2018-12-31 |
Company details: Seelos Therapeutics, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1 | |
| -4.83% | +3.51% | +55.00% | +63.79% | 66.7B | |
| +0.02% | +1.07% | +11.72% | +75.63% | 56.88B | |
| -1.34% | +2.98% | +25.08% | +100.18% | 56.53B | |
| +5.09% | +9.89% | +27.19% | +105.85% | 46.49B | |
| +2.62% | +1.68% | +29.16% | +35.86% | 44.8B | |
| +8.24% | +0.51% | +215.16% | +794.74% | 41.59B | |
| -1.86% | +10.13% | +28.14% | +55.48% | 35.35B | |
| -2.97% | -9.84% | +90.91% | +73.49% | 33.29B | |
| +5.19% | +1.62% | -39.69% | +368.87% | 25.1B | |
| Average | +1.02% | +2.38% | +49.18% | +185.99% | 40.67B | |
| Weighted average by Cap. | +0.65% | +3.07% | +49.90% | +165.88% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SEELQ Stock
- Company Seelos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
